Executive Vice President - Alternative Finance
Gregg R. Honigblum, co-founder and Chief Revenue Officer. Mr. Honigblum has over 30 years of experience as a financier for emerging growth companies specializing in the healthcare sector. From 2001-2013, he was the CEO and co-founder of Creation Capital LLC and Creation Capital Advisors, an investment banking firm and Broker Dealer with offices in New York City and Austin, TX. Mr. Honigblum provided strategic advisory services and raised over $500 million in private equity for numerous businesses in the healthcare space. He has been instrumental in providing early stage capital for Myriad Genetics, Inc(symbol MYGN), and Acacia Biosciences which merged with Rosetta Inpharmatics, Inc. and is now a wholly owned subsidiary of Merck. From 2014-2016, he was a Managing Director at Westlake Securities in Austin, TX leading their healthcare banking practice. Mr. Honigblum holds a BA in Economics from the University of Texas at Austin.